Heart Failure Reviews

, Volume 22, Issue 2, pp 219–228 | Cite as

Heart failure in the elderly: ten peculiar management considerations

  • Feras BaderEmail author
  • Bassam Atallah
  • Lisa F Brennan
  • Rola H Rimawi
  • Mohammed E Khalil


Chronic heart failure (HF) is a disease with significantly higher prevalence in the elderly or patients older than 65 years old. Typically, older patients have more risk factors for HF, more comorbidities, and are more likely to have recurrent admissions for acute decompensations. With HF burden on health care systems primarily related to hospital and nursing home costs, it is critical that elderly patients are approached with a clear understanding of certain unique clinical, laboratory, imaging, and pharmacokinetic differences that can alter their management and outcomes. Psychosocial factors have major implications on adherence to therapy as well as decisions on advanced care for elderly HF patients. In this article, we highlight ten peculiar management considerations when approaching older patients with HF. We discuss issues related to epidemiology, diagnostic challenges, pharmacotherapy, and palliative care; all of which can impact this unique population and, more importantly, the disease burden as a whole.


Geriatric heart failure Polypharmacy Comorbidities 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Haldeman GA, Croft JB, Giles WH et al (1999) Hospitalization of patients with heart failure: national hospital discharge survey 1985–1995. Am Heart J 137:352–360CrossRefPubMedGoogle Scholar
  2. 2.
    Saczynski JS, Darling CE, Spencer FA et al (2009) Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: the Worcester Heart Failure Study. J Am Geriatr Soc 57(9):1587–1594CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123:e18–209CrossRefPubMedGoogle Scholar
  4. 4.
    Barker WH, Mullooly JP, Getchell W (2006) Changing incidence and survival for heart failure in a well-defined older population, 1970–1974 and 1990–1994. Circulation 113:799–805CrossRefPubMedGoogle Scholar
  5. 5.
    McMurray JJ, Stewart S (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83:596–602CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Sulaiman K, Panduranga P, Al-Zakwani I et al (2015) Clinical characteristic, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (GULF CARE). Eur J Heart Fail 17:374–384CrossRefPubMedGoogle Scholar
  7. 7.
    AlHabib KF, Elasfar AA, AlBackr H et al (2011) Design and preliminary results of the Heart Function Assessment Registry Trial in Saudi Arabia (HEARTS) in patients with acute and chronic heart failure. Eur J Heart Fail 13:1178–1184CrossRefPubMedGoogle Scholar
  8. 8.
    Jugdutt BI (2010) Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev 15:401–405CrossRefPubMedGoogle Scholar
  9. 9.
    Jugdutt B (ed) (2014) Aging and heart failure: mechanisms and management. Springer Science + Business Media, New York, New YorkGoogle Scholar
  10. 10.
    Kitzman DW, Gardin JM, Gottdiener JS et al (2001) Cardiovascular Health Research Group. Importance of heart failure with preserved systolic function in patients > or =65 years age. CHS research group. Cardiovascular health study. Am J Cardiol 87(4):413–419CrossRefPubMedGoogle Scholar
  11. 11.
    Masoudi FA, Havranek EP, Smith G et al (2003) Gender, age and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41:217–223CrossRefPubMedGoogle Scholar
  12. 12.
    Alcinder, Fitzgerald. “Geriatrics: managing congestive heart failure.” Emergency Physicians Monthly. Web: Accessed July 1, 2016
  13. 13.
    Debacker, Noel. History and physical examination of the older adult. History and Physical Examination of the Older Adult. June 1999. Web: chapters/history_physical_exam.pdf Accessed July 1, 2016.
  14. 14.
    Maisel AS, Krishnaswamy P, Nowal R et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347(3):161–167CrossRefPubMedGoogle Scholar
  15. 15.
    Ray P, Arthaud M, Lefort Y et al (2004) EPIDASA study group. Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea. Intensive Care Med 30:2230–2236CrossRefPubMedGoogle Scholar
  16. 16.
    Thygesen K (2012) Mair J, Mueller C, et al. Study group on biomarkers in cardiology of the ESC working group on acute cardiac care. Eur Heart J 33:2001–2006CrossRefPubMedGoogle Scholar
  17. 17.
    Ueda R, Yokouchi M, Suzuki T et al (2003) Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med 114:266–270CrossRefPubMedGoogle Scholar
  18. 18.
    Wei JY (1992) Age and the cardiovascular system. N Engl J Med 327:1735–1739CrossRefPubMedGoogle Scholar
  19. 19.
    Bandy B, Davison AJ (1990) Mitochondrial mutation may increase oxidative stress. Implication for carcinogenesis and ageing? Free Radic Biol Med 8:523–539CrossRefPubMedGoogle Scholar
  20. 20.
    Thomas G. Echocardiographic evaluation in elderly: what is new? In cardiological society of India: Cardiology Update, 1st edition. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2014. p. 283–287.Google Scholar
  21. 21.
    Kitzman DW, Edwards WD (1990) Age-related changes in the anatomy of the normal human heart. J Gerontol 45(2):M33–M39CrossRefPubMedGoogle Scholar
  22. 22.
    Abd El-Aziz TA (2008) A-wave acceleration: a new Doppler echocardiographic index for evaluation of left ventricular diastolic dysfunction in elderly patients. Angiology 59(4):435–441CrossRefPubMedGoogle Scholar
  23. 23.
    Wong CY, Chaudhry SI, Desai MM et al (2011) Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med 124:136–143CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Murad K, Goff DC (2015) Morgan Tm, et al. burden of comorbidities and functional and cognitive impairments in elderly patients at the initial diagnosis of heart failure and their impact on total mortality: the cardiovascular health study. JACC Heart Fail 3:542–550CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Arnett DK, Goodman RA, Halperin JL et al (2014) AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American heart Association, American College of Cardiology, and US Department of Health and Human Services. Circulation 130:1662–1667CrossRefPubMedGoogle Scholar
  26. 26.
    Sadik GZ, Atallah B, Stapleton J et al (2016) Appropriateness of evidence based therapy in patients referred to a specialized heart failure clinic in a developing country. J Card Fail 22(8):S36CrossRefGoogle Scholar
  27. 27.
    Juurlink DN, Mamdani MM, Lee DS et al (2004) Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 351:543–551CrossRefPubMedGoogle Scholar
  28. 28.
    Abdelhafiz AH (2002) Heart failure in older people: causes, diagnosis and treatment. Age Ageing 31:29–36CrossRefPubMedGoogle Scholar
  29. 29.
    Dharmajan K, Dunlay SM (2016) Multimorbidity in older adults with heart failure. Clin Geriatr Med 32:277–289CrossRefGoogle Scholar
  30. 30.
    Yancy CW, Jessup M, Bozkurt B et al (2016 Sep) 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure. J Card Fail 22(9):659–669CrossRefGoogle Scholar
  31. 31.
    Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRefPubMedGoogle Scholar
  32. 32.
    O’Connor MN, Gallagher P, O’Mahoney D (2012) Inappropriate prescribing: criteria, detection, and prevention. Drugs Aging 29(6):437–452CrossRefPubMedGoogle Scholar
  33. 33.
    Mahoney D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C et al (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44:213–218CrossRefGoogle Scholar
  34. 34.
    American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63:2227–2246CrossRefGoogle Scholar
  35. 35.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M et al (2009) Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol 104:107–115CrossRefPubMedGoogle Scholar
  36. 36.
    Komajda M, Hanon O, Hochadel M, Lopez-Sendon JL, Follath F et al (2009) Contemporary management of octogenarians hospitalized for heart failure in Europe: euro heart failure survey II. Eur Heart J 30:478–486CrossRefPubMedGoogle Scholar
  37. 37.
    Maison P, Cunin P, Hemery F et al (2005) Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study. Eur J Clin Pharmacol 61:445–451CrossRefPubMedGoogle Scholar
  38. 38.
    Leibundgut G, Pfisterer M, Brunner-La Rocca HP (2007) Drug treatment of chronic heart failure in the elderly. Drugs Aging 24(12):991–1006CrossRefPubMedGoogle Scholar
  39. 39.
    Mangoni AA (2005) Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamics and therapeutic considerations. Drugs Aging 22(11):913–941CrossRefPubMedGoogle Scholar
  40. 40.
    Shi S, Morike K, Klotz U (2008) The clinical implications of ageing for rational drug therapy. Eur J Pharmacol 64:183–199CrossRefGoogle Scholar
  41. 41.
    Micromedex® healthcare series [intranet database]. Version 5.1. Greenwood Village, Colo: Thomson MicromedexGoogle Scholar
  42. 42.
    Zand JM, ed. Drug information. In: Post TW, ed. UpToDate. Waltham, Mass.: UpToDate; 2016. Accessed December 6, 2016.
  43. 43.
    Giardini A, Martin MT, Cahir C, Lehane E, Menditto E et al (2016) Toward appropriate criteria in medication adherence assessment in older persons: position paper. Aging Clin Exp Res 28(3):371–381CrossRefPubMedGoogle Scholar
  44. 44.
    Maher RL Jr, Hanlon JT, Hajjar ER (2014) Clinical consequences of polypharmacy in the elderly. Expert Opin Drug Saf 13(1):57–65CrossRefPubMedGoogle Scholar
  45. 45.
    Michalsen A, Konig G, Thimme W (1998) Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80:437–441CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Hughes CM (2004) Medication non-adherence in the elderly: how big is the problem? Drugs Aging 21(12):793–811CrossRefPubMedGoogle Scholar
  47. 47.
    Lavan AH, Gallagher P (2016) Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf 7(1):11–22CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Senni M (1997) Congestive heart failure in elderly patients. Mayo Clin Proc 72:453–460CrossRefPubMedGoogle Scholar
  49. 49.
    “Heart failure—palliative care: MedlinePlus Medical Encyclopedia.” U.S National Library of Medicine. Apr. 2015. Web: Accessed July 1, 2016
  50. 50.
    Martinez-Selles M (2009) End-stage heart disease in the elderly. Revista Española de Cardiología English edition. Rev Esp Cardiol 62(04):409–421CrossRefPubMedGoogle Scholar
  51. 51.
    Forman, Daniel. “Heart failure in the elderly.” 2003. Medscape, Web: Accessed July 1, 2016.
  52. 52.
    Kristjanson LJ, Aoun S (2004) Palliative care for families: remembering the hidden patients. Can J Psychiatr 49(6):359–365Google Scholar
  53. 53.
    Goodlin SJ (2009) Palliative care in congestive heart failure. J Am Coll Cardiol 54:386–396CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Feras Bader
    • 1
    Email author
  • Bassam Atallah
    • 2
  • Lisa F Brennan
    • 3
  • Rola H Rimawi
    • 4
  • Mohammed E Khalil
    • 1
  1. 1.Cleveland Clinic Abu Dhabi, United Arab EmiratesHeart and Vascular InstituteAbu DhabiUAE
  2. 2.Department of Pharmacy ServicesCleveland Clinic Abu Dhabi, United Arab EmiratesAbu DhabiUAE
  3. 3.Levine College of Health SciencesWingate University School of PharmacyWingateUSA
  4. 4.ScottsdaleUSA

Personalised recommendations